title: Parenteral antibiotic therapy in outpatients: quality assurance and other issues in a protohospital.
abstract: Antibiotics can be administered parenterally to outpatients in order to achieve adequate serum levels to treat such infections as endocarditis, osteomyelitis and diabetic foot infections, and to eradicate such difficult-to-treat organisms as methicillin-resistant Staphylococcus aureus, cephalothin-resistant gram-negative bacilli and invasive fungal infections. At Intracare, a free-standing clinic for such therapy, 3,247 outpatients have been treated to date. Besides the type of infection, criteria for patient selection include improvement in the patient's condition, a desire to leave the hospital, an adequate support structure at home, patient compliance and adequate insurance coverage. The most frequently treated infections have been osteomyelitis, followed by infection of skin and skin structure. Ceftriaxone and cefazolin are the two most frequently utilized antibiotics. The program at Intracare is used to examine such issues of quality assurance as patient compliance, therapeutic outcome, adverse events and patient satisfaction in this largely unregulated multibillion dollar industry. It is likely that such infusion centers will evolve into protohospitals, day care centers for present-day medical-surgical patients not occupying intensive care beds.
authors.affiliation: Division of Infectious Diseases, Fairfax Hospital, Falls Church, Va.
authors.forename: L J
authors.initials: LJ
authors.lastname: Eron
mesh_terms: D000554:Ambulatory Care Facilities; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D007262:Infusions, Intravenous / Q000191:economics; D007349:Insurance, Health, Reimbursement; D006278:Medicare; D010349:Patient Compliance; D011785:Quality Assurance, Health Care; D014481:United States
chemical_list: D000900:Anti-Bacterial Agents